ARCHIVES

Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies

This article is from The Cancer Letter archive.

Vol. 36 No. 24 | June 25, 2010

Download PDF Visit The Full Archive

Related Articles

Bills in House, Senate, would give FDA authority over tobacco products.

June 4, 2004

Plan posted for “public comment” on Dialogue’s Web site; who will respond, Dialogue or NCI? Cost estimate of network significantly reduced.

December 12, 2003

Congress Plans to Accelerate Development of Drugs, Devices

December 19, 2014

ASCO Members Pick Schilsky as President-Elect; Five Elected to Society’s Board of Directors.

February 16, 2007

Cancer Meetings Listed

November 1, 1996

Large Bowel Study Expansion Hampered By Lack Of Coordination, NCI Admits

May 17, 1974